Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-25

Clinical Trial Update: Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo [Phase 2]

View source ↗

Summary

Phase 2 trial comparing four dose levels of Minirin Melt (desmopressin) to placebo in nocturia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minirin Melt (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 2 | Status: COMPLETED | Results posted: 2012-05-25